This Presentation contains or incorporates by reference statements that are not historical in nature and that are intended to be, and are hereby identified as, "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995. Statements which are not historical in nature, including the words "anticipate," "estimate," "could," "should," "may," "plan," "seek," "expect," "believe," "intend," "target," "will," "project," "focused," "outlook", "goal", "designed" and variations of t ...

Company Overview - Onto Innovation is a high-tech capital equipment company specializing in optical process solutions for semiconductor and related markets[6] - The company has a trailing twelve month (TTM) revenue of $846 million[7] - The company's TTM adjusted EPS is $3.99[7] - The company has over 10,000 employees[7] - The company has over 1,500 active metrology & inspection tools installed[7] Market Trends and Growth Drivers - The AI server market is expected to grow at a compound annual growth rate (CAGR) of 42%[9] - Chiplet packaging is expected to grow at a CAGR of 80%[9] - Global EV charging station is expected to grow at a CAGR of 46%[9] - The company estimates its Total Available Market (TAM) will increase threefold due to the AI era, reaching $12.3 billion[12] Financial Guidance and Long-Term Model - The company's Q2 2024 revenue guidance is between $230 million and $240 million[32] - The company's Q2 2024 gross margin guidance is between 52% and 54%[32] - The company's Q2 2024 diluted EPS guidance is between $1.14 and $1.26[32] - The company's long-term organic operating model targets $1.8 billion in revenue[33]

Financial Performance & Growth - Onto Innovation's revenue reached $983 million, a 20% year-over-year increase in 2024[5] - The company's non-GAAP EPS increased by 40% year-over-year to $5.24 in 2024[5] - Operating cash flow was approximately $250 million, representing about 25% of revenue in 2024[5] - The company outperformed the overall WFE (Wafer Fab Equipment) market with a 70% growth rate[6] - Onto Innovation's three-year CAGR (Compound Annual Growth Rate) from 2021 to 2024 outperformed WFE[7] Market Opportunities & New Products - The AI packaging market is expected to grow at a 10% CAGR through 2028[9] - New products are expected to add approximately $300 million in Served Available Market (SAM) by 2026 in AI packaging[21] - The company launched four new products for packaging, expanding its growth opportunities in AI packaging[19] - The total films SAM (Served Available Market) is projected to reach ~$400 million, with an 8% CAGR for common films[44] - A new unpatterned inspection technology is expected to address a $250 million SAM in 2028[51]

Business Transformation and Financial Performance - Ryder's transformative actions have led to significantly higher earnings and an improved return profile, outperforming prior cycles[10] - The company expects post-transformation returns (2025F) to be well above pre-transformation peak returns (2018)[17] - A multi-year maintenance cost savings initiative aims for $50 million in savings[20] - Synergies from the Cardinal acquisition are expected to yield $40-60 million by 2026[20] Market Position and Growth Strategy - Ryder is a leader in North American logistics and transportation outsourcing, with significant growth opportunities from secular trends and large addressable markets[10] - The company's balanced growth strategy focuses on accelerating growth in higher-return Supply Chain Solutions (SCS) and Dedicated Transportation Solutions (DTS), with moderate growth and increased returns in Fleet Management Solutions (FMS)[14] - Ryder redeployed approximately 8,800 vehicles in 2024[29] Revenue and Cash Flow - Approximately 90% of Ryder's operating revenue is contractual, providing multi-year recurring operating cash flow[41] - The company forecasts free cash flow of $0.5 billion for 2025[48] - Ryder's total revenue for 2024 was $12.6 billion[24] Financial Targets - Ryder targets high single-digit operating revenue growth over the long term[59] - The company's long-term leverage goal is a debt-to-equity ratio between 2.5x and 3.0x[59]

Company Highlights - PetVivo focuses on the estimated $11 billion companion animal veterinary care and product sales market[8, 103] - Spryng, with OsteoCushion Technology, is designed to restore joint mechanics for managing lameness and joint-related issues like osteoarthritis[8, 103] - The company has a strong IP portfolio with twelve U S and nine foreign issued patents[8, 22, 84, 103] Spryng Technology and Clinical Data - Spryng utilizes biocompatible materials similar to natural cartilage components to improve joint function[18] - Clinical studies show that 77.8% of dogs experienced a greater than 3-point reduction in total CBPI score after Spryng treatment for hip osteoarthritis[64] - Another canine stifle OA/CCL disease study showed that 55% of dogs had improved mGCPS at 28 days, and by 84 days, responders improved in VLS and LOAD scores by 50%[67] - Tolerance studies in both dogs and cats confirmed the excellent safety profile of Spryng, with no abnormalities observed in physical exams, CBC, or chemistry analysis after injections[58, 61] Market and Distribution - The U S pet spend increased from $123.6 billion in 2021 to $138 billion in 2022, with veterinary care and products being a leading growth driver at $11 billion in 2021[91] - PetVivo has distribution agreements with MWI and Covetrus, and engagements with wholesale partners like Clipper Distributing Company and Vedco, Inc[8, 49, 103]

Investor Presentation Certain statements made in this news release are "forward-looking statements" within the meaning of Section 27A of the Securities Exchange Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking information includes estimates of the company's future financial and operating performance. Certain data and statements in this presentation, other than those setting forth strictly historical information, are forward-looking and are not guar ...

STRONG FOUNDATION. STRONGER FUTURE. Simpson Manufacturing Co., Inc. Investor Presentation March 2024 Safe Harbor This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements generally can be identified by words such as "anticipate," "believe," "estimate," "expect," "intend," "plan," "outlook, ...

STRONG FOUNDATION. STRONGER FUTURE. Simpson Manufacturing Co., Inc. Investor Presentation November 2024 Safe Harbor This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements generally can be identified by words such as "anticipate," "believe," "estimate," "expect," "intend," "plan," "outlo ...

Company Overview - Amkor Technology is the largest OSAT (Outsourced Semiconductor Assembly and Test) company headquartered in the U S, with over 55 years of experience [5] - The company plans to break ground on a U S facility in 2025 [5] - Amkor's advanced packaging revenue CAGR (2019-2024) is 16% [5] - In 2024, advanced packaging accounted for 82% of Amkor's revenue [5] - Amkor's 2024 revenue was $6 3 billion, with capital expenditures of $744 million [5] Market and Strategy - The semiconductor market is projected to reach $1 trillion by 2030 [8] - Amkor focuses on industry megatrends such as 5G communications, HPC (High Performance Computing) and AI, automotive electronics, and IoT devices [18] - The company leverages advanced packaging leadership to optimize power, performance, and area [19] - Amkor has a broad geographic footprint with 13 million square feet (1 2M sqm) of manufacturing space [21] Financial Performance - Amkor expects 2025 capital expenditures to be around $850 million [42] - In 2024, Amkor's revenue was $6 318 billion, gross profit was $933 million, and operating income was $438 million [44, 45, 46] - The company's EPS (Earnings Per Share) in 2024 was $1 43 [47] - Amkor's free cash flow in 2024 was $359 million [51]

DarioHealth Corp. Corporate Presentation January 2025 Forward-looking statement This presentation of DarioHealth Corp. ("Dario", the "Company", "we" and "our") and statements of our management or agents related thereto contain or may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 (the "Act"). Statements which are not historical reflect our current expectations and projections about our future results, performance, liquidity, financial condition, ...